Study to Evaluate Adverse Events and Change in Disease Activity With Oral Tablets of Upadacitinib in Adult Participants With Non-Segmental Vitiligo
Public ClinicalTrials.gov record NCT04927975. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study to Evaluate the Safety and Efficacy of Upadacitinib in Subjects With Non-Segmental Vitiligo
Study identification
- NCT ID
- NCT04927975
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- AbbVie
- Industry
- Enrollment
- 185 participants
Conditions and interventions
Conditions
Interventions
- Placebo Drug
- Upadacitinib Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 29, 2021
- Primary completion
- Jan 12, 2023
- Completion
- Aug 28, 2023
- Last update posted
- Oct 7, 2024
2021 – 2023
United States locations
- U.S. sites
- 20
- U.S. states
- 12
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of California Irvine /ID# 229390 | Irvine | California | 92697-1385 | — |
| Stanford University /ID# 228000 | Redwood City | California | 94063 | — |
| Clearlyderm Dermatology /ID# 227993 | Boca Raton | Florida | 33428 | — |
| New Horizon Research Center /ID# 229403 | Miami | Florida | 33165-3372 | — |
| Park Avenue Dermatology, PA /ID# 229400 | Orange Park | Florida | 32073 | — |
| ForCare Clinical Research /ID# 228010 | Tampa | Florida | 33613-1244 | — |
| Dawes Fretzin, LLC /ID# 227996 | Indianapolis | Indiana | 46256 | — |
| Tufts Medical Center /ID# 228087 | Boston | Massachusetts | 02111-1552 | — |
| Duplicate_UMass Chan Medical School /ID# 228066 | Worcester | Massachusetts | 01655 | — |
| Duplicate_Michigan Center for Research Company /ID# 228054 | Clarkston | Michigan | 48346 | — |
| Hamzavi Dermatology /ID# 228056 | Fort Gratiot | Michigan | 48059 | — |
| Remington-Davis Clinical Research /ID# 229401 | Columbus | Ohio | 43215 | — |
| Essential Medical Research, LLC /ID# 228074 | Tulsa | Oklahoma | 74137-2842 | — |
| Oregon Dermatology and Research Center /ID# 228007 | Portland | Oregon | 97210 | — |
| Oregon Medical Research Center /ID# 228073 | Portland | Oregon | 97223 | — |
| Duplicate_Medical University of South Carolina /ID# 228067 | Charleston | South Carolina | 29425 | — |
| International Clinical Research - Tennessee LLC /ID# 228059 | Murfreesboro | Tennessee | 37130-2450 | — |
| Bellaire Dermatology Associates /ID# 228004 | Bellaire | Texas | 77401 | — |
| University of Texas Health Science Center at Houston /ID# 229399 | Houston | Texas | 77030-1501 | — |
| Virginia Clinical Research, Inc. /ID# 228050 | Norfolk | Virginia | 23502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 15 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04927975, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 7, 2024 · Synced May 12, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04927975 live on ClinicalTrials.gov.